46th week of 2020 patent applcation highlights part 24 |
Patent application number | Title | Published |
20200354387 | NOVEL COMPOSITION OF 7,9-DODECADIENYL-1-ACETATE ISOMERS AND PROCESS FOR PRODUCTION THEREOF | 2020-11-12 |
20200354388 | Real-Time Fluorescence Imaging Sensor for Measuring Glutathione in Organelle and Preparation Method Therefor | 2020-11-12 |
20200354390 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | 2020-11-12 |
20200354391 | ORGANIC LUMINESCENT MATERIAL INCLUDING 3-DEUTERIUM-SUBSTITUTED ISOQUINOLINE LIGAND | 2020-11-12 |
20200354392 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | 2020-11-12 |
20200354393 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANOMETALLIC COMPOUND, AND DIAGNOSTIC COMPOSITION INCLUDING ORGANOMETALLIC COMPOUND | 2020-11-12 |
20200354394 | LIPID-BASED PLATINUM COMPOUNDS AND NANOPARTICLES | 2020-11-12 |
20200354395 | ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF | 2020-11-12 |
20200354396 | METHOD FOR PREPARING TULATHROMYCIN | 2020-11-12 |
20200354397 | PHOSPHORAMIDITE SYNTHONES FOR THE SYNTHESIS OF SELF-NEUTRALIZING OLIGONUCLEOTIDE COMPOUNDS | 2020-11-12 |
20200354398 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | 2020-11-12 |
20200354399 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | 2020-11-12 |
20200354400 | METHODS AND SYSTEMS FOR PROTEIN REFOLDING | 2020-11-12 |
20200354401 | GIARDIA RECOMBINANT ANTIGENS, PURIFICATION OF POLYCLONAL ANTI-GIARDIA IGG AND IGY ANTIBODIES AND GIARDIA DETECTION | 2020-11-12 |
20200354402 | PEPTIDE COMPOSITIONS AND RELATED METHODS | 2020-11-12 |
20200354403 | DUAL MASS SPECTOMETRY-CLEAVABLE CROSSLINKING REAGENTS FOR PROTEIN-PROTEIN INTERACTIONS | 2020-11-12 |
20200354404 | PEPTIDOMIMETIC AGENTS, SYNTHESIS AND USES THEREOF | 2020-11-12 |
20200354405 | METHOD FOR ACTIVATING HELPER T CELL | 2020-11-12 |
20200354406 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR OX40 | 2020-11-12 |
20200354407 | PEPTIDE INHIBITORS OF INSULIN-DEGRADING ENZYME | 2020-11-12 |
20200354408 | ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS | 2020-11-12 |
20200354409 | Adenoviral Polypeptide IX Increases Adenoviral Gene Therapy Vector Productivity and Infectivity | 2020-11-12 |
20200354410 | MODIFIED S1 SUBUNIT OF THE CORONAVIRUS SPIKE PROTEIN | 2020-11-12 |
20200354411 | Chimeric Molecule for Targeting c-Myc in Cells | 2020-11-12 |
20200354412 | ANTI-CANCER DNA VACCINE EMPLOYING PLASMIDS ENCODING SIGNAL SEQUENCE, MUTANT ONCOPROTEIN ANTIGEN, AND HEAT SHOCK PROTEIN | 2020-11-12 |
20200354413 | STABILIZED PEPTIDE-MEDIATED TARGETED PROTEIN DEGRADATION | 2020-11-12 |
20200354414 | SPLIT INTEIN MEDIATED PROTEIN POLYMERIZATION FOR MICROBIAL PRODUCTION OF MATERIALS | 2020-11-12 |
20200354415 | TREATMENT OF ISCHEMIA | 2020-11-12 |
20200354416 | SELF-ASSEMBLED NANOSTRUCTURES OF ELASTIN-AND RESILIN-BASED BLOCK COPOLYPEPTIDES WITH STIMULI RESPONSIVENESS AND RESILIENCE FOR DRUG DELIVERY SYSTEM, TISSUE ENGINEERING AND REGENERATIVE MEDICINE AND METHODS OF PREPARING THE SAME | 2020-11-12 |
20200354417 | ANTI-INFLAMMATORY COMPOUNDS AND METHODS OF USE | 2020-11-12 |
20200354418 | HMGB1 ANTAGONIST TREATMENT OF ACUTE LUNG INJURY | 2020-11-12 |
20200354419 | COMPOSITIONS AND METHODS OF USE THEREOF FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | 2020-11-12 |
20200354420 | GENE THERAPY FOR DIABETIC NEUROPATHY USING AN HGF ISOFORM | 2020-11-12 |
20200354421 | NEUREGULIN-4 COMPOUNDS AND METHODS OF USE | 2020-11-12 |
20200354422 | METHODS FOR CARDIOMYOCYTE SURVIVAL, PROLIFERATION OR DIFFERENTIATION BY NRG-2 | 2020-11-12 |
20200354423 | MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF SECRETED PROTEINS | 2020-11-12 |
20200354424 | XCR1 BINDING AGENTS AND USES THEREOF | 2020-11-12 |
20200354425 | ACYLATED OXYNTOMODULIN PEPTIDE ANALOG | 2020-11-12 |
20200354426 | GLUCAGON AND GLP-1 CO-AGONISTS FOR THE TREATMENT OF OBESITY | 2020-11-12 |
20200354427 | PARATHYROID HORMONE-ANTI-RANKL ANTIBODY FUSION COMPOUNDS | 2020-11-12 |
20200354428 | ANALOGUES OF PARATHYROID HORMONE (1-34) THAT FUNCTION AS AGONISTS OF THE PARATHYROID HORMONE RECEPTOR-1 AND DISPLAY MODIFIED ACTIVITY PROFILES | 2020-11-12 |
20200354429 | POLYNUCLEOTIDES ENCODING RELAXIN | 2020-11-12 |
20200354430 | LONG-ACTING COAGULATION FACTORS AND METHODS OF PRODUCING SAME | 2020-11-12 |
20200354431 | MUTABLE COLLAGENOUS TISSUE FROM ECHINODERMS | 2020-11-12 |
20200354432 | Highly Oriented Collagen Fibril Bundle and Method of Producing Same | 2020-11-12 |
20200354433 | RECOMBINANT MUTANT (alpha)1-ANTITRYPSIN AND PREPARATION AND USES THEREOF | 2020-11-12 |
20200354434 | A NOVEL CIP2A VARIANT AND USES THEREOF | 2020-11-12 |
20200354435 | ANTIBODIES THAT POTENTLY NEUTRALIZE RABIES VIRUS AND OTHER LYSSAVIRUSES AND USES THEREOF | 2020-11-12 |
20200354436 | ANTIBODIES THAT POTENTLY NEUTRALIZE RABIES VIRUS AND OTHER LYSSAVIRUSES AND USES THEREOF | 2020-11-12 |
20200354437 | MONOCLONAL ANTIBODIES AND COCKTAILS FOR TREATMENT OF EBOLA INFECTIONS | 2020-11-12 |
20200354438 | MONOCLONAL ANTIBODIES AND COCKTAILS FOR TREATMENT OF EBOLA INFECTIONS | 2020-11-12 |
20200354439 | BISPECIFIC MOLECULES COMPRISING AN HIV-1 ENVELOPE TARGETING ARM | 2020-11-12 |
20200354440 | METHODS OF TREATING HEMOLYTIC DISORDERS COMPRISING ADMINISTERING AN ANTI-C3b ANTIBODY | 2020-11-12 |
20200354441 | TREATMENT OF DISORDERS | 2020-11-12 |
20200354442 | METHODS OF MODULATING INFLAMMASOME ACTIVITY TO TREAT INFLAMMATORY CONDITIONS | 2020-11-12 |
20200354443 | METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF ANTAGONIST | 2020-11-12 |
20200354444 | COMPOUNDS AND METHODS TARGETING INTERLEUKIN-19 | 2020-11-12 |
20200354445 | METHODS AND COMPOSITIONS FOR THE IMPROVEMENT OF LYSOSOMAL FUNCTION AND TREATMENT OF NEURODEGENERATIVE DISEASE | 2020-11-12 |
20200354446 | ANTAGONISTS OF IL-6 TO PREVENT OR TREAT CACHEXIA, WEAKNESS, FATIGUE, AND /OR FEVER | 2020-11-12 |
20200354447 | SINGLE-CHAIN MULTIVALENT BINDING PROTEINS WITH EFFECTOR FUNCTION | 2020-11-12 |
20200354448 | ROR1 ANTIBODIES | 2020-11-12 |
20200354449 | HUMAN ANTIBODIES BINDING TO ROR2 | 2020-11-12 |
20200354450 | ANTIBODIES AGAINST CANINE PD-1 | 2020-11-12 |
20200354451 | CHIMERIC ANTIGEN RECEPTORS COMPRISING A HUMAN TRANSFERRIN EPITOPE SEQUENCE | 2020-11-12 |
20200354452 | CARS AND BISPECIFIC ANTIBODIES FOR TREATMENT OF MANTLE CELL LYMPHOMA | 2020-11-12 |
20200354453 | STABLE FORMULATIONS OF ANTI-TIGIT ANTIBODIES ALONE AND IN COMBINATION WITH PROGRAMMED DEATH RECEPTOR 1 (PD-1) ANTIBODIES AND METHODS OF USE THEREOF | 2020-11-12 |
20200354454 | ANTI-PD-1 ANTIBODIES AND METHODS OF USE THEREOF | 2020-11-12 |
20200354455 | ANTI-CTLA-4 ANTIBODIES AND METHODS OF USE THEREOF | 2020-11-12 |
20200354456 | METHODS FOR TREATING CANCER | 2020-11-12 |
20200354457 | BISPECIFIC ANTIBODIES COMPRISING AN ANTIGEN-BINDING SITE BINDING TO LAG3 | 2020-11-12 |
20200354458 | Bifunctional Fusion Protein Targeting CD47 and PD-L1 | 2020-11-12 |
20200354459 | ANTI-GLYCOPROTEIN IIb/IIIa ANTIBODIES | 2020-11-12 |
20200354460 | Bispecific antibodies against EGFR and PD-1 | 2020-11-12 |
20200354461 | ANTI-IL-6/IL-6R ANTIBODIES AND METHODS OF USE THEREOF | 2020-11-12 |
20200354462 | USE OF GHR-106 MONOCLONAL ANTIBODY AS A GNRH ANTAGONIST | 2020-11-12 |
20200354463 | FORMULATIONS OF HUMAN ANTI-RANKL ANTIBODIES, AND METHODS OF USING THE SAME | 2020-11-12 |
20200354464 | ANTIBODIES TO OPGL | 2020-11-12 |
20200354465 | Methods Related to Alemtuzumab | 2020-11-12 |
20200354466 | NEUTRALIZING ANTIBODIES AND METHODS OF USE THEREOF | 2020-11-12 |
20200354467 | ANTI-CD5L ANTIBODY AND USES THEREOF | 2020-11-12 |
20200354468 | ANTI-CD133 MONOCLONAL ANTIBODIES AND RELATED COMPOSITIONS AND METHODS | 2020-11-12 |
20200354469 | CD47 TARGETED THERAPIES FOR THE TREATMENT OF INFECTIOUS DISEASE | 2020-11-12 |
20200354470 | ANTI-PRESENILIN ANTIBODY FOR USE IN THE PREVENTION AND/OR TREATMENT OF CANCER | 2020-11-12 |
20200354471 | TETRAVALENT TLR9 BISPECIFIC ANTIBODY | 2020-11-12 |
20200354472 | ANTIBODIES TARGETING GLIOBLASTOMA STEM-LIKE CELLS AND METHODS OF USE THEREOF | 2020-11-12 |
20200354473 | MULTISPECIFIC ANTIGEN-BINDING MOLECULES HAVING BLOOD COAGULATION FACTOR VIII (FVIII) COFACTOR FUNCTION-SUBSTITUTING ACTIVITY AND PHARMACEUTICAL FORMULATIONS CONTAINING SUCH A MOLECULE AS AN ACTIVE INGREDIENT | 2020-11-12 |
20200354474 | METHODS AND COMPOSITIONS RELATING TO ANTI-CHI3L1 ANTIBODY REAGENTS | 2020-11-12 |
20200354475 | ANTIGEN BINDING MOLECULES SPECIFIC FOR AN ANTI-CD19 SCFV | 2020-11-12 |
20200354476 | CHIMERIC SMALL MOLECULES FOR THE RECRUITMENT OF ANTIBODIES TO CANCER CELLS | 2020-11-12 |
20200354477 | FLUORESCEIN-SPECIFIC CARS EXHIBITING OPTIMAL T CELL FUNCTION AGAINST FL-PLE LABELLED TUMORS | 2020-11-12 |
20200354478 | PROTEINACEOUS HETERODIMER AND USE THEREOF | 2020-11-12 |
20200354479 | Surface Functionalization of Cellulose and Other Substrates | 2020-11-12 |
20200354480 | WATER SOLUBLE NITRIC OXIDE-RELEASING POLYGLUCOSAMINES AND USES THEREOF | 2020-11-12 |
20200354481 | METHODS OF PRODUCING GLYCAN POLYMERS | 2020-11-12 |
20200354482 | Modified Conjugated Diene-Based Polymer and Rubber Composition Including the Same | 2020-11-12 |
20200354483 | System and Method for Rapid Dump Tank Heating | 2020-11-12 |
20200354484 | PHOTOLABILE BETA-DICARBONYL COMPOUNDS | 2020-11-12 |
20200354485 | Olefin polymerization Ziegler-Natta catalyst components and process for the production of olefin polymers therewith | 2020-11-12 |
20200354486 | MAKING LOW-SODIUM RESIN | 2020-11-12 |
20200354487 | Method for Producing Polymer | 2020-11-12 |